Biohaven (BHVN) Interest Coverage Ratio (2021 - 2026)
Biohaven (BHVN) posted Interest Coverage Ratio of 11.97 for Q1 2026, down 333.42% sequentially from 2.76 in Q3 2025, and down 639.26% YoY from 2.22 in Q1 2025.
Biohaven (BHVN) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Biohaven has reported Interest Coverage Ratio for 6 years, with the latest figure at 11.97 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 639.26% year-over-year to 11.97 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 60.05 (down 789.72% YoY) and the FY2025 annual result came in at 2.38, up 18.37% from the prior year.
- Interest Coverage Ratio eased to 11.97 in Q1 2026 per BHVN's latest filing, from 2.76 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.36 in Q1 2024 and troughed at 1285.43 in Q3 2023.
- A 5-year average of 135.65 and a median of 2.76 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio tumbled 11926.26% in 2023, then soared 99.97% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 0.99 in 2022, then soared by 40.02% to 0.59 in 2023, then declined by 5.55% to 0.63 in 2024, then slumped by 341.7% to 2.76 in 2025, then sank by 333.42% to 11.97 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 11.97, 2.76, and 3.71 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | -1.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.65 |
| Mar 31, 2026 | -11.97 |
| Sep 30, 2025 | -2.76 |
| Jun 30, 2025 | -3.71 |
| Mar 31, 2025 | -1.62 |
| Dec 31, 2024 | -0.63 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | -1.30 |
| Mar 31, 2024 | -0.36 |
| Dec 31, 2023 | -0.59 |
| Sep 30, 2023 | -1,285.43 |
| Jun 30, 2023 | -356.10 |
| Mar 31, 2023 | -238.60 |
| Dec 31, 2022 | -0.99 |
| Sep 30, 2022 | -10.69 |
| Jun 30, 2022 | -119.53 |
| Dec 31, 2021 | -0.94 |